Background: We assessed the number, proportion, and clinical relevance of diabetes self-
validated treatment guidelines. This is critical for low-and middleincome countries where weakness of health care services and shortage of health care professionals are particularly grave.
Health-related smartphone applications (apps) started gaining prominence in 2010, and studies have demonstrated the utility of smartphone apps in complementing diabetes care. Meta-analyses have found that apps can help to improve blood glucose control and strengthen the perception of self-care in people with diabetes by enhancing health knowledge. 8, 9 The number of smartphone users have surpassed 2 billion in 2016 and is expected to increase 10 to 2.86 billion by 2020. Currently, the Android and Apple markets represent 80% and 15% of the apps market share, respectively. The number of health apps worldwide have more than doubled to 318 000 in 2017 in a span of 2 years. 11 According to the latest report from the IQVIA Institute for Human Data Science, strong clinical evidence in app efficacy exists for diabetes care
and may be considered for incorporation into standard of care recommendations. 11 While the evidence is still weak, the number of diabetes management apps is expected to further increase in magnitude and capabilities to help meet the unmet needs.
While health app developments are advancing rapidly, the number of apps intended for diabetes self-management is unknown. Studies of health apps are also generally limited to English language apps. Disparities in health apps access and usage exist within and between health systems. 12, 13 With the high number of non-English-speaking people with diabetes worldwide, it is imperative to understand the global diabetes apps landscape and appreciate the applicability of high-quality mobile health (mHealth) apps for different populations and contexts.
To get an overview of the diabetes apps landscape, we assessed the number and proportion of diabetes self-management apps in major languages spoken by 10 countries with the greatest number of people with diabetes and assessed the clinical relevance of selected apps in each language.
| METHODS
The methods used in this study is to obtain a global overview of the state of diabetes apps for self-management of diabetes. This paper is a descriptive but not a review paper nor a comprehensive assessment of the content of diabetes smartphone apps.
| Selection of apps
The method of app selection and identification is similar to the process of a systematic literature review. 14 In brief, China, India, United States of America (USA), Brazil, Russian Federation, Mexico, Indonesia, Egypt, Japan, and Pakistan were identified as the 10 countries with the largest number of people with diabetes based on the latest NCD-RisC publication. 15 App users are assumed to prefer to use apps in their mother tongue. Hence, the languages spoken and used most frequently by majority of the population in these countries were included in this study. The titles and descriptions of Android and iOS smartphone apps were extracted in 10 languages with a search strategy. All extracted app titles and descriptions were checked for language relevance on Google translate and sorted by the identified languages. Other unspecified languages that were identified were dropped from the analysis.
Duplicated apps in the same language and on the same app platform were then removed before being screened for relevance to diabetes self-management by trained reviewers.
| Search strategy
Diabetes related search terms such as "Diabetes," "Glucose," "Insulin,"
and variations of these words were searched on the Android and iOS platforms in June 2017 in 10 languages. Chinese language apps in the Android market were additionally searched on third-party platforms such as "Baidu," "Wandoujia," and "360 Zhushou" due to Google restrictions in China. Native speakers translated the terms from English to Chinese, Arabic, Spanish, Portuguese, Russian, Japanese, Hindi, Urdu, and Bahasa Indonesia.
| App screening
App titles and descriptions were screened in English, Chinese, Arabic, Spanish, Portuguese, Russian, Japanese, Bahasa Indonesia, and Urdu.
The purpose of app screening was to identify the number of apps relevant for diabetes self-management from the search terms for a more accurate assessment of the proportion of apps in different languages.
Self-management in this context refers to behaviour or actions an individual can partake without the presence of a health care professional to manage diabetes. Apps in all languages were correctly classified by the language detector except for English apps, as a mixture of English and other languages are mentioned in some app descriptions. These apps were checked and reclassified into the appropriate language.
Approximately 1% of the apps were translated to multiple languages and were duplicated across the languages covered by this study. All apps were screened by native speakers.
Prior to the full screening, 100 English apps were selected randomly for adjustments of the inclusion and exclusion criteria by 6 reviewers independently. Fleiss' generalized kappa coefficient, an adaptation of Scott's pi, was used to calculate the interrater agreement among all reviewers. 16 An agreement of between 60% and 80% represents a reasonably good agreement between the reviewers. 17 Disagreements were discussed, and the apps were rescreened until a good agreement was achieved between the reviewers. The final inclusion and exclusion criteria are shown below:
Inclusion criteria
• Targeted at people with all types of diabetes
• For self-management or informal care givers of people with diabetes
• Recipes specifically for diabetes Exclusion criteria
• Apps intended solely for health care provider's use
• Medical dictionaries for doctors or patients
• Apps for diabetes prevention or prediction of diabetes risk
• Apps promoting pharmaceutical products without any diabetes self-management components
• Apps for general well-being without specific focus on diabetes
• Apps intended for other chronic diseases other than diabetes
• Apps espousing traditional cure
• Demonstration/trial apps
| Apps assessment
Selected apps were downloaded and assessed against a checklist (see Table 1 ) developed with reference to the 2017 American Diabetes Association clinical guidelines. 18 A clinically relevant app should facilitate diabetes self-care through knowledge empowerment, selfawareness promotion, added convenience, and goal setting reliably.
Apps should also cover important domains such as physical activity, nutrition, weight, medicines management, smoking cessation, foot and eye care, psychosocial care, and lipids and blood pressure management. Up to 3 apps in each language were selected from the list of apps screened to be suitable for diabetes self-management based on availability, downloads, and popularity. Selected apps must be suitable for adults with type 2 diabetes and at least have information or a functionality supporting blood glucose monitoring, as optimal blood glucose control is often the primary outcome of diabetes management.
A criterion is considered to have been met if the app contains content or functionality in the diabetes care domains listed in Table 1 .
| Data analysis
Apps were profiled according to app platform and language. Descriptive summary statistics was used to collate the number and proportion of apps according to languages. Excel 2016 was used to conduct all analyses.
| RESULTS
Overall, the diabetes-related search terms identified 3374 Android Reclassified apps in languages that were not in the scope of this study were excluded from the analysis.
| Proportion of apps by languages
The app description screening revealed 27.6% more iOS apps relevant to diabetes self-management compared with Android apps. English and Chinese language apps constitute over 80% of apps for diabetes self-management among the 10 languages spoken by countries with the largest number of people with diabetes on both app platforms (see Figure 1 ). The inclusion of 11 other languages and dialects prior to screening did not alter the proportion of English and Chinese apps significantly. Chinese language apps have the largest proportion of relevant diabetes self-management apps on the Android platform, possibly due to the large app user base and low barriers of entry to the many third-party android app platforms. The iOS market is dominated by English language diabetes apps.
| Relevance of apps from diabetes-related search terms to diabetes self-management
The proportion of apps relevant to diabetes self-management was determined by computing the percentage of apps included from screening the list of apps obtained from the searches. Overall, the searches made by the diabetes-related search terms returned apps that were of low relevance to diabetes self-management (see Figure 2 ).
The iOS apps in Urdu and Hindi were all identified from the English search terms, as the search terms in these languages did not return any results. There were 5 or less apps identified for diabetes self-management in these 2 languages on each platform, and the apps were mainly focused on diet and education. Despite the high number of apps returned by the English search terms, only approximately a quarter of the apps were determined to be relevant for diabetes selfmanagement. The Chinese Android apps have the highest proportion (55.6%) of apps relevant for diabetes self-management, possibly due to additional searches conducted on third-party platforms that dominate the Chinese app market, such as Baidu, Wandoujia, and 360
Zhushou.
| Clinical relevance of diabetes apps
The profile of apps checked against the list of criteria drawn from the American Diabetes Association guidelines is shown in Figure 3 Android apps were assessed due to the existence of third-party Android platforms in China. Eighteen apps were assessed across all languages. Except for English, Chinese, and Japanese apps, we could not find more than 2 apps with at least information provision or recording functionality of blood glucose level in other languages. Only one app Physical activity Provide information on the importance and recommended amount of physical activity. Tracking of exercise levels will help to guide treatment decisions and promote self-awareness on the progress of diabetes management.
Nutrition therapy has an integral role in overall diabetes management, and each person with diabetes should be actively engaged in education, self-management, and treatment planning with his or her health care team, including the collaborative development of an individualized eating plan. All individuals with diabetes should receive individualized medical nutrition therapy (MNT), preferably provided by a registered dietitian who is knowledgeable and skilled in providing diabetesspecific MNT.
Nutrition therapy Provide information on healthy food choices and food to avoid. A food database with nutritional information should be provided for reference. Meal logging will also guide treatment decision and promote self-awareness of the dietary patterns.
In overweight and obese patients with type 2 diabetes, modest weight loss, defined as sustained reduction of 5% of initial body weight, has been shown to improve glycaemic control and to reduce the need for glucoselowering medications. For many obese individuals with type 2 diabetes, weight loss >5% is needed to produce beneficial outcomes in glycaemic control, lipids, and blood pressure, and sustained weight loss of ≥7% is optimal.
Weight management Provide information on the importance of weight loss in obese people with diabetes. BMI and weight tracking can guide treatment decisions and promote selfawareness in the progress of weight loss.
Advise all patients not to use cigarettes and other tobacco products or e-cigarettes. Include smoking cessation counselling and other forms of treatment as routine component of diabetes care.
Smoking cessation
Provide information on the importance of smoking cessation in people with diabetes.
The care team, which includes the patient, should prioritize timely and appropriate intensification of lifestyle and/or pharmacological therapy for patients who have not achieved the recommended metabolic targets. To inform this process, providers should routinely assess medication adherence.
Medicines management Provide information on common diabetes medications and the importance of medication adherence. Tracking of medication can guide treatment decisions (ie, whether to increase medication dosage) and promote self-awareness in people with diabetes.
Psychosocial care should be integrated with a collaborative, patient-centred approach and provided to all people with diabetes, with the goals of optimizing health outcomes and health-related quality of life. Providers should consider assessment for symptoms of diabetes distress, depression, anxiety, disordered eating, and cognitive capacities using patient-appropriate standardized and validated tools at the initial visit, at periodic intervals, and when there is a change in disease, treatment, or life circumstance.
Psychosocial issues
Tracking of mood at different time points of the day can alert the health care provider of coping issues and factors that may cause irregular blood glucose levels.
(Continues) available in various Indian vernacular languages (including Hindi and Urdu) met the criteria for apps assessment.
Apps in English and Chinese languages had many more users and more comprehensive diabetes management functionalities in general, compared with other languages. None of the apps assessed met all criteria for information provision and app functionalities. Although the English apps were very close to meeting all app functionalities criteria, none of these top downloaded apps have any form of information provision. Two of three Chinese apps assessed had full information provision, but both apps contained online retail services and dubious information sources for users. It is also noteworthy that of the apps with information provision, none of the apps assessed had information cited from accredited sources.
As blood glucose level information or functionality was set as the basis of selecting apps for assessment, all but one app had blood glucose monitoring functionality. Insulin, food, and oral medication logging were found in two-thirds of the apps assessed. Only 5 of the 18 apps allowed blood glucose level goals to be set, and 3 apps had mood tracker functions. Less than a third of the apps assessed provided information on diabetes management, which may imply either a lack of demand for diabetes education or perceived low importance of diabetes education by app developers. Hypertension/blood pressure control
Blood pressure tracking and monitoring will help the user and health care provider to predict and understand the risks of cardiovascular diseases.
In adults not taking statins, it is reasonable to obtain a lipid profile at the time of diabetes diagnosis, at an initial medical evaluation, and every 5 years thereafter, or more frequently if indicated. Obtain a lipid profile at initiation of statin therapy and periodically thereafter, as it may help to monitor the response to therapy and inform adherence.
Lipid management Cholesterol level tracking can assist in formulating personalized nutritional therapies.
When prescribed as part of a broad educational programme, self-monitoring of blood glucose (SMBG) may help to guide treatment decisions and/or self-management for patients taking less frequent insulin injections or noninsulin therapies. When prescribing SMBG, ensure that patients receive ongoing instruction and regular evaluation of SMBG technique, SMBG results, and their ability to use SMBG data to adjust therapy. When prescribing continuous glucose monitoring (CGM), robust diabetes education, training, and support are required for optimal CGM implementation and ongoing use.
SMBG
Provide information on the importance and ways to perform SMBG. Monitoring/ tracking of blood glucose levels and insulin intake will help to guide treatment decisions and promote self-awareness in the control of blood glucose levels.
Abbreviation: BMI, body mass index.
relevance covered all the important app functionalities and provided information from accredited sources. Several observations can be derived from our unprecedented findings.
| Perception of health apps influences its adoption
There is potential for mHealth to improve the quality of health care in all countries. However, mHealth currently lags in adoption compared with other industries, which undermines benefit to population health. For the technologically astute smartphone user, health apps can assist to relief stress from the demands of managing a newly diagnosed or long-standing chronic disease. A useful app will enable better collection, organization, dissemination, and management of information, which brings convenience and helps in the adjustment of lifestyle changes. However, the adoption of a health app is dependent on the perception of the utility of the health apps by patients, clinicians, and app developers. For example, less than a third of the apps assessed in our study provided information on diabetes management, which may imply either a lack of demand Improper information dissemination and use of apps can be detrimental to the user. In fact, miscalculation of insulin doses by an app can potentially be fatal to diabetic patients. 19, 20 It was also observed during the apps screening that many apps provided recommendations or claimed to cure diabetes without any evidence backing, which can mislead the user to act inappropriately. Therefore, elements that would ensure trust in use of apps for diabetes of both patients and clinicians, such as government support in implementation, funding, quality assessment, regulation, and interoperability, should be addressed to improve perceptions on health apps and to drive mHealth adoption.
| Recommendations on health apps should be incorporated as clinical guidance
There is a lack of mHealth regulation regardless of the number of apps in a language. This problem is intensified in countries with a range of health apps for consumers to choose from. Support from an authoritative body and providing clinicians with more guidance on app selection and communication with patients will enhance the incorporation of app use into the clinical pathway. Recommendations should be made based on at least an available, accredited, and clinically relevant app.
App functionalities and content should be assessed to identify potential "useful" attributes for diabetes self-management, and this information could be used to create a trusted platform to guide app selection.
For example, the US Food and Drug Administration has issued a consultation on draft guidance for industry and Food and Drug Administration staff, 21 and a digital innovation action plan to commit to the regulation of digital health products. The UK National Health Service launched a beta digital apps library in April 2017 to host approved (from a technical perspective) health care apps that can be trusted by the public. 22 Apps that are listed on the National Health Service platform are assessed using a set of tools to ensure its safety and validity.
| Populations most in need often do not have access to technology
The inverse care law, which states that "the availability of good medical care tends to vary inversely with the need for it in the population served," is observed in the use of mHealth. 13, 23 Rural populations and those living in low-and middle-income countries have lower access to medical resources and are more in need of alternative solutions such as health apps. Our study however showed that their needs are not being catered for at present. Although studies have demonstrated the ability of technology to improve access to care, inequality is still high between younger and older and more and less deprived populations. 13 We need apps with elderly friendly features, 24 as the elderly population is capable of adopting mHealth. While e-commerce and m-commerce have grown tremendously in China, mHealth presents more challenges in terms of pricing and regulations. 25 Underdeveloped app markets can focus on creating high-quality apps through partnerships, learning from examples, and translation of high-quality apps to context-specific content and languages for the population of interest. Currently, only 12% of the Indian population speak English. Most of the older and rural Indian population rely on vernacular language for communication, but most Indian apps for diabetes self-management only have an English description, which implies that the app user has to be proficient in English to use an app in a vernacular language. This presents a major gap as future internet and smartphone populations in India will be older, more rural, more gender balanced, and more vernacular. There are a few apps that are translated into various Indian vernacular languages, but no single or a combination of apps covered the full spectrum of diabetes self-management. An example is the "Humrahi" app, which educates patients and care givers on diabetes care. Translation of app languages will improve the adoption of apps with larger population coverage.
| Future directions and limitations
As diabetes is a complex disease, a stand-alone app is less likely to be effective in helping the patient to achieve good diabetes treatment outcomes. A good app should be tailored to users' requirements and supported by health care-affiliated systems. In addition, governments or insurers can consider reimbursing health apps that have shown to be effective in disease management to better integrate apps into the overall care path.
Moving forward, mHealth in diabetes care should focus more on the safety and effectiveness of apps in diabetes care. Frameworks should be in place to control the quality of apps used for chronic disease management. The reliability of the educational content or advice given by the app is of paramount importance, as such information can potentially elicit behavioural change. 26 For example, diabetes apps can be checked for the advice given on acute complications surrounding blood glucose fluctuations, and the prevention and management of complications and multimorbidities. These frameworks should also be regularly updated as per accepted diabetes guidelines to keep up with the evidence base. We have since developed a tool to systematically assess the content, functionality, and usability of all diabetes apps.
There are some limitations to this study. First, description screening enables the identification of potential apps for diabetes self-management, but not the utility of the app, as the usability and content of the apps were not assessed. Second, the number of apps in the market increases quickly, limiting any precise estimation of app numbers.
Furthermore, studies may lag behind estimates on the number of people with diabetes with constant updates. Third, apps with multiple language versions may be counted more than once. Apps intended for the Indian or Pakistani population may also be described in English, but the screening does not enable the identification of the country of origin of the developer, thus limiting the classification of app by country. Lastly, relevance to diabetes self-management is context specific and dependent on individual needs, but this study covered a larger range of apps to suit different needs.
| CONCLUSION
In conclusion, every patient with diabetes who has a smartphone, speaking one of the above 10 languages, can access an app for diabetes self-management. English and Chinese literate patients with diabetes will have more app choices to self-manage diabetes but may face challenges in selecting the most suitable app. A larger variety of health apps can cater to more diverse user needs, but too many unregulated apps that do not meet users' expectations may lead to app fatigue and erosion of trust in this mode of support for diabetes care. In low-resource settings, one high-quality app for a specific population may suffice to complement diabetes care. While there is an app for everyone, not everyone can have an app. The future of mHealth is rosy with the rise in smartphone ownership and an increase in positive evidence. The onus is on governments and regulators to develop minimum quality standards and quality assurance processes (eg, through curation and certification) to assist the industry, clinicians, and patients alike and to drive mHealth adoption.
